首页 | 本学科首页   官方微博 | 高级检索  
     

药品价格问题的研究概述
引用本文:张仁伟,胡善联,张崖冰. 药品价格问题的研究概述[J]. 中华医院管理杂志, 2002, 18(11): 646-648
作者姓名:张仁伟  胡善联  张崖冰
作者单位:200032,上海,复旦大学公共卫生学院卫生经济学教研室
摘    要:目的:掌握药品费用的增长情况及价格变化、生产成本及流通环节利润分配等情况,为药品价格管理的改革和完善提供依据。方法:采用回顾性抽样调查的方法,对1995-2002年全国临床使用量大的药品价格进行调查,同时对1999年全国18个省市80个制药厂家的生产经营状况、20个省市48家药品批发企业的利润及相关影响因素等进行了分析。结果:20世纪90年代中国药品费用的增长速度在10%以上,高于GDP的增长速度。药品价格指数平均高于总物价指数,药品生产的完全成本占其零售价格的54%。结论:我国药品价格可以认为是适宜的,但流通环节分占了太多利润,使制药行业缺乏充足的研究开发资金。

关 键 词:药品价格 问题 研究概述 生产成本
修稿时间:2002-07-02

A brief account of research on the prices of drugs
ZHANG Renwei,HU Shanlian,ZHANG Yabing. Health Economics. A brief account of research on the prices of drugs[J]. Chinese Journal of Hospital Administration, 2002, 18(11): 646-648
Authors:ZHANG Renwei  HU Shanlian  ZHANG Yabing. Health Economics
Affiliation:ZHANG Renwei,HU Shanlian,ZHANG Yabing. Health Economics Department of Fudan University Public Health College,Shanghai 200032,China
Abstract:Objective To find out about the increase in the expenses of drugs as well as the changes of prices, manufacturing costs, and the distribution of profits in the manufacturing process so as to provide basis for the reform and perfection of the control of drug prices. Methods Using the method of retrospective sampling, investigations were made into the prices of drugs extensively used clinically throughout the country from 1995 to 2002 and analyses were conducted into the manufacturing and operating status of 80 pharmaceutical companies in 18 provinces of the nation and profits and other relevant influencing factors in 48 drug wholesaling enterprises in 20 provinces of the nation in 1999. Results The increment speed of the expenses of drugs in the 90s of the 20 th century in China was above 10%, higher than the increment speed of the GDP; the price index of drugs was on overage higher than the general price index; and the complete manufacturing costs of drugs accounted for 54% of their retail prices. Conclusion The prices of drugs in China might be regarded as appropriate, and yet too large an amount of profits goes into the process of circulation, resulting in insufficient funds for the pharmaceutical industry to conduct research and development.
Keywords:Drug  Price  Manufacturing cost
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号